Webinar: RADx Tech for Maternal Health Challenge Q+A - CIMIT MAIN

Responsive Image

We are thrilled to announce that we’ve been selected as one of the first spokes of the ARPA-H Investor Catalyst Hub network!

We are excited to be a part of this nationwide network dedicated to accelerating groundbreaking advances in science and medicine—all in pursuit of better health outcomes for everyone.

Learn more >

Funding Opportunities and Events

News and Annoucements

null Webinar: RADx Tech for Maternal Health Challenge Q+A

RADx Tech for Maternal Health Informational Webinar

The NIH has launched the RADx Tech for Maternal Health Challenge to accelerate the development of maternal health diagnostics or other remote sensing technologies to improve postpartum outcomes. If you have questions or would like to learn more, please join us for our informational webinar.

During the webinar, the RADx Tech for Maternal Health team will share an overview of the Challenge, background on its impetus and helpful information on the submission process, such as eligibility and evaluation criteria. There will also be time for a live question and answer session.

When: September 22, 2022, 2PM ET

This session has passed. 

Watch the recording here >

If you have any accessibility or technical questions about the webinar, please contact: cimitcommunications@partners.org.

For questions pertaining to the Challenge, please email: 
NICHDRADxTechMaternalHealth@mail.NIH.gov.

For those of you that cannot make this webinar, please note that it will be recorded and a link will be uploaded to this page and here.

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, CIMIT has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.